SCHEMBL4903548

SCHEMBL4903548

Cc1nn(-c2ccccc2)cc1C(N)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
KDM4E B2RXH2 5/20 0.60
PKM P14618 2/20 0.60
PARP1 P09874 1/20 0.57
PARP2 Q9UGN5 1/20 0.57
PARP3 Q9Y6F1 1/20 0.57
MAPT P10636 3/20 0.56
LMNA P02545 3/20 0.56
HPGD P15428 3/20 0.56
NPC1 O15118 1/20 0.56
HTT P42858 1/20 0.56
RAB9A P51151 1/20 0.56
ADORA3 P0DMS8 1/20 0.51
ADORA2A P29274 1/20 0.51
ADORA2B P29275 1/20 0.51
ADORA1 P30542 1/20 0.51
KAT2B Q92831 1/20 0.51
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4298023 0.86 ALDH1A1 (0.59) ALDH1A1KDM4EPKMMAPTLMNA
SCHEMBL10604729 0.85 MAPT (0.57) ALDH1A1KDM4EPKMMAPTLMNA
SCHEMBL29332121 0.84 CA12 (0.55) ALDH1A1KDM4EPKMPARP1PARP2
SCHEMBL28315894 0.83 ALDH1A1 (0.56) ALDH1A1KDM4EPKMMAPTLMNA
SCHEMBL30140734 0.83 NPC1 (0.46) ALDH1A1KDM4EPKMPARP1PARP2
SCHEMBL6258731 0.83 SLC9A1 (0.56) ALDH1A1KDM4EPKMPARP1PARP2
Hydrochloric Acid SCHEMBL6312270 0.82 SLC9A1 (0.54) ALDH1A1KDM4EPKMPARP1PARP2
SCHEMBL10321185 0.82 HTT (0.57) ALDH1A1KDM4EPKMMAPTLMNA
SCHEMBL2031958 0.81 PARP1 (0.59) ALDH1A1KDM4EPKMPARP1PARP2
SCHEMBL28210218 0.81 PARP1 (0.59) ALDH1A1KDM4EPKMPARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008016811-A2 AMINOPIPERIDINES AND REALTED COMPOUNDS NEUROGEN CORPORATION (US) 2008-02-07 WO disclosed